Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) は上場企業です ヘルスケア セクターの Medical - Pharmaceuticals 業界で事業展開. 本社所在地は Nashville, DE, アメリカ. 現CEOは Mark L. Baum.
HROWL を有する IPO日 2021-05-07, 217 名の正社員, に上場 NASDAQ Global Market, 時価総額 $1.37B.
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
